Program Profile
Last updated from Access Observatory: 09 Sept 2020

Pink Ribbon, Red Ribbon (Africa)

Pink Ribbon Red Ribbon (PRRR) is an innovative partnership leveraging public and private investments to combat cervical and breast cancer in Sub-Saharan Africa and Latin America. It is an independent affiliate of the George W. Bush Institute, a global partnership of national governments, non-governmental (NGO) and multilateral organizations, foundations, and corporations with a shared goal of reducing deaths from cervical cancer and breast cancer in low- and middle-income countries.

The PRRR aim to accomplish the following goals:

  • Reduce deaths from cervical cancer by 25 percent among women screened and treated in partner countries;
  • Achieve at least 80 percent coverage of vaccination against the human papillomavirus (HPV), which causes most cases of cervical cancer;
  • Screen at least 80 percent of the appropriate target populations for pre invasive cervical cancer, and treat those found with lesions;
  • Increase awareness of, and reduce stigma about, breast and cervical cancer, and promote the early detection of the disease; and
  • Create and test innovative approaches to sustainability, financing, service delivery, and laboratory and data systems that can be scaled up and used globally.

The PRRR envision a future where no woman is denied opportunity because she cannot access life-saving cancer care. A future where all women, regardless of where they live, can thrive and contribute to their communities.

The activities of PRRR include:

  • Educating communities about breast and cervical cancer
  • Vaccinating girls against human papilloma virus (HPV)
  • Screening women for breast and cervical cancer
  • Treating women for cervical pre-cancer with low cost methods such as cryotherapy
  • Increasing access to diagnostics, products and treatments, and providing care and support, including transportation
  • Training and equipping public and private providers to screen and treat cervical and breast cancer

In 2016, 316,652 women have been screened for cervical cancer, 119,192 girls have received all doses of the HPV vaccination and 22,039 women have been treated with cryotherapy or LEEP for cervical cancer. The PRRR collaboration is a locally developed and driven initiative which has a global view. The Ministries of Health own and direct the project from identifying project scope and geography to hosting personnel that is seconded. In all countries initial planning meeting were held with multi-sectoral stakeholders. Bi-Monthly teleconferences are held with each country and annual meetings for all countries are also a part of joint planning, monitoring and reporting. The Bristol-Myers Squibb Foundation (BMSF) has collaborated with PRRR as a platform to build on investments and gains made in the fight against HIV and AIDS.

The data for this program has been reviewed by both the companies and the Access Observatory team.